花滑天才女孩瓦利耶娃樣本藥物濃度法庭文件事實核查

通過檢索國際體育上訴法庭聽證會文件，關於瓦利耶娃樣本藥物濃度及相關專家證詞事實如下：

第一，樣本濃度為2.1ng/ml。

第二，檢測的技術下限為10ng/ml。

第三，專家證言一個運動員口服一片35毫克曲美他嗪后一天，尿樣本濃度應該為960-9000ng/ml。2ng/ml 如果是口服攝入，起碼是在5到7天前。

第四，瓦利耶娃團隊認為由於樣本濃度極度低下，存在污染和技術錯誤的可能性。要求對B樣本進行檢測。法庭採納其要求。

相關文欄位落拷貝如下：

The concentration of Trimetazidinedetectedwas estimatedat 2.1 ng/ mL

single use of a dose of 35mg TMZ leads to a concentration of the substance in a sample a day later between 966 ng/ml 9000 ng/ ml. A concentration of 2 ng/ ml would require a single use of 35 mg a minimum 5 – 7 days before the competition. 

Moreover, the DADC also took into consideration that the Athlete's legal representative disputed the positive results of the Sample alleging that the concentration of 2.1 ng/ml, is well below the technical limit of detection of Trimetazidine , which is 10 ng/ml, and may be a technical mistake of the sample analysis in the laboratory and she confirmed at the hearing the intention to request the analysis of the 「 B 」 sample.

法庭文件鏈接：https://int.nyt.com/data/documenttools/court-of-arbitration-for-sport-ruling-on-kamila-valieva/412fe80e6c099377/full.pdf